Litigation Update: June 2010 District Court Filings

     The following cases are reported as being filed in the U.S. District Court for the District of Maryland in June 2010 (source: Justia.com):

  • Patent docket:

       

    • WhitServe LLC v. Benesch Friedlander Coplan & Aranoff LLP, Brinks Hofer Gilson & Lione, PC, Dinsmore & Shohl LLP, Edwards Angell Palmer & Dodge LLP, EMC Corp, General Electric Co., Intel Corp., Kusner & Jaffe, Mueting, Raasch & Gebhardt, PA and Wilmer Cutler Pickering Hale and Dorr LLP, No. 8:2010cv01639 (filed June 18, 2010) 

       

    • Genzyme Corporation v. Sandoz, Inc., No. 1:2010cv01715 (filed June 25, 2010)
       
  • Trademark docket:

     

    • B Line, Inc. v. Outrageous Outlet, Yossef Benzakan and David Azoulin, No. 1:2010cv01670 (filed June 22, 2010)
       
  • Copyright docket:

     

    • Broadcast Music, Inc , EMI Blackwood Music Inc. and Still on Top Publishing Corp. v. Orange Ball, Inc. and Ho S. Chang, No. 1:2010cv01560 (filed June 14, 2010)
       
    • 88 LLC v. RC Matrice LLC and Rene Mitchell, No. 8:2010cv01607 (filed June 16, 2010)
       
    • Micro Focus(US), Inc. v. Ashley Furniture Industries, Inc., No. 8:2010cv01623 (filed June 17, 2010)
       
    • Micro Focus(US), Inc. v. Ashley Furniture Industries, Inc., No. 8:2010cv01624 (filed June 17, 2010)
       
    • Jonathan Hanson v. Here Publishing, Inc. and Here Media, Inc., No. 1:2010cv01712 (filed June 25, 2010)

 

Litigation Update: May 2010 District Court Filings

   The following cases are reported as being filed in the U.S. District Court for the District of Maryland in May 2010 (source: Justia.com):

  • Patent dockets:
    • Genzyme Corporation v. Watson Laboratories, Inc., No. 1:2010cv01323 (filed May 24, 2010); this Hatch-Waxman patent infringement lawsuit was brought by Genzyme after Watson sought Food and Drug Administration (FDA) approval to market in the US a generic version of the company's Renvela(R) drug product (sevelamer carbonate).  According to FDA information, Genzyme, based in Cambridge, MA, is the New Drug Applicant for this reference listed drug, which covers oral suspensions and tablet forms.  Renvela is indicated for "phosphate binding," and, according to Genzyme's website, is a "first-line monotherapy for controlling serum phosphorus in patients with Chronic Kidney Disease (CKD) — on dialysis without calcium or metal accumulation."  Genzyme's patent exclusivity reportedly extends until September 16, 2014.  
       
    • MIH International, LLC v. Weber Orthopedic, Inc., No. 8:2010cv01127 (filed May 5, 2010)

     
  • Trademark dockets:
    • Gifford's Dairy, Inc. v. Gifford's Holdings, LLC, Gifford's Ice Cream & Candy Company, Inc., and Deal Metrics, LLC., No. 1:2010cv01294 (filed May 20, 2010); Gifford's Ice Cream & Candy Co., based in Silver Spring, MD, calls itself Washington, DC's oldest ice cream company (with retail stores in Baltimore, Bethesda, Chevy Chase, and Rockville, MD, and downtown DC).  Gifford's Dairy, based in Skowhegan, ME, is the owner of the registered trademarks GIFFORD'S and GIFFORD'S ICE CREAM FAMILY OWNED THE ICE CREAM STAND ICE CREAM

  • Copyright dockets:
    • Advanced Education Systems, LLC d/b/a TrainingPro v. MTI Services Corporation d/b/a Mortgage Training Institute, No. 1:2010cv01253 (filed May 18, 2010)